Erytech Pharma SA ADS debut about 14.7 pct above IPO price
Nov 10 (Reuters) - :Erytech Pharma SA ADS open at $26.68 in debut on the NASDAQ versus IPO price of $23.26 per ADS.
Latest Developments forErytech Pharma SA
- Erytech Reports Results Of Phase 2b Study Of Eryaspase For The Treatment Of AML
- Erytech Pharma announces trading suspension of its ordinary shares on Euronext paris
- Erytech Pharma 9M net loss widens to 20.8 million euros
- Erytech Pharma sees U.S. IPO of up to 4.26 mln ordinary shares in form of ADSs